The Chicago Entrepreneur

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.

Previous post The Tell: Wall Street’s bearishness may offer another reason to buy, says BofA, as stocks rally
Next post : MongoDB stock streaks toward best day ever after big beat, forecast